glp 1 and tooth decay Ozempic Teeth: Protect Your Smile on GLP-1 Patients taking Ozempic or other

How long will they be on it

It is related to thymosin beta-4 and can be used in conjunction with BPC-157 in recovery plans

Davies MJ, Bergenstal R, Bode B, Kushner RF, Lewin A, Skjoth TV, Andreasen AH, Jensen CB, DeFronzo RA

Donner J, Freyer J, Davison S, et al

The study discussed here was relatively small, involving only 17 patients, and more extensive clinical trials are needed to fully understand: Long-term safety profile Optimal dosing protocols Patient selection criteria Potential side effects Interactions with other treatments Additionally, patients should be aware that BPC-157 is not yet FDA-approved for human use, and treatment is typically offered on a research or compassionate use basis by qualified practitioners